Northeast Pharm Group Co., Ltd. (hereinafter referred to as “NEPG”, stock code: 000597) is a listed company under Liaoning Fangda Group Industry Co., Ltd. (hereinafter referred to as "Fangda group"). The company, formerly known as the NEPG General Factory, was founded in 1946. It has assisted in the construction of 52 pharmaceutical companies in 19 cities and provinces and cultivated more than 1300 cadres to the country. It is known as the cradle of China's national pharmaceutical industry.

At present, NEPG has major business sectors such as API（active pharmaceutical ingredient）,chemical preparation, pharmaceutical commerce,pharmaceutical commerce, pharmaceutical engineering and biomedicine, covering the whole industrial chain of pharmaceutical R & D, manufacturing and distribution, with nearly 8000 employees and a total asset of 12 billion yuan. The company mainly produces ten series of high-quality products such as vitamin series drugs, anti infective system drugs, gynecological and obstetric system drugs, digestive system drugs, urinary system drugs, anti-virus series drugs, cardiovascular and cerebrovascular series drugs, analgesic and antitussive series drugs, biological diagnosis series and great health field series, as well as more than 400 kinds of APIs, pharmaceutical intermediates and preparation products, The leading products are exported to more than 100 countries and regions.

The company has a strong product manufacturing system. The preparation production base covers an area of 180000 square meters, with more than 30 production lines annual production capacity of 10 billion tablets (pills,tablets and bottles). The API production base covers an area of 910000 square meters. It is a national intelligent manufacturing demonstration factory for bulk APIs and pharmaceutical intermediates. Its main products include vitamin C series, L-carnitine series, Fosfomycin series, piracetam, carboprost methyl ester, amantadine, Sucralfate, berberine, chloramphenicol, etc.It also extends to the downstream pharmaceutical industry chain in NEPG, forming comprehensive competitive advantages that are difficult to be duplicated.

NEPG is a national green factory with the most advanced environmental protection treatment system in China to realize the all-round treatment of sewage, tail gas, noise and solid waste. The treatment capacity of API sewage treatment system reaches 50000 m3 / day, and the technical level is leading in the whole industry. The incinerator can handle 9000 tons of hazardous waste throughout the year, and the tail gas emission meets the EU standard. The circular economy industrial park realizes the resource treatment of production waste and turns waste into treasure.

NEPG has a sound quality management system, and the product quality meets the latest quality standards such as GMP, EP, USP, JP, BP and CP,etc. Many products have passed international high-end certification such as EDQM, FDA, Japan's Ministry of health and welfare, BRC, halal, kosher, etc. The leading products have passed the registration and quality audit in the United States, Europe, Japan, Brazil, Russia, Poland and other countries and regions.

NEPG is not only an important pharmaceutical production and export base in China, but also has independent business companies such as pharmaceutical research institute, engineering design company, equipment manufacturing and installation company, international trading company, measurement and testing company and dangerous chemicals transportation company. 5 of  them are high-tech enterprises.

Northeast Pharm has pharmaceutical  business network covers all prefecture level cities and counties in Liaoning and extends to the three northeastern provinces. The Northeast Pharmacy has more than 100 chain stores,the e-commerce business has achieved  online and offline integration. Business model innovation is continued to advance.

NEPG has two well-known trademarks , of “Dongbei”and “Fumeixin”, and as well as many famous trademarks in cities and provinces, ranking 28th on the list of "2018 top 100 industrial enterprises in China's chemical and pharmaceutical industry".

Facing the future development, NEPG will adhere to the enterprise value of "operating enterprises must be beneficial to the nation, enterprises and employees", and strive to build Northeast Pharmaceutical into an internationally famous and domestic leading large-scale comprehensive medical and health industry group.